CHUNGHWA CHEMICAL SYNTHESIS & BIOTE

CHUNGHWA CHEMICAL SYNTHESIS & BIOTE CO., LTD. is a factory.

Company Introduction:

CHUNGHWA CHEMICAL SYNTHESIS & BIOTE CO., LTD. is a prominent manufacturer based in Taiwan, specializing in chemical synthesis and biotechnology. Established in 1964, the company has a rich history of developing and producing high-quality active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and various fine and specialty chemicals. They are recognized for their robust research and development capabilities, state-of-the-art manufacturing facilities, and a steadfast commitment to innovation and quality. Beyond their own product portfolio, CHUNGHWA CHEMICAL SYNTHESIS & BIOTE also provides contract manufacturing organization (CMO) services, utilizing their extensive expertise in complex chemical synthesis to serve the global pharmaceutical and chemical industries.

Main Product Categories:

1. Active Pharmaceutical Ingredients (APIs)

- Immunosuppressants: Mycophenolate Mofetil, Mycophenolic Acid, Tacrolimus, Sirolimus, Everolimus.

- Cardiovascular Agents: Cilostazol, Pitavastatin Calcium.

- CNS Agents: Donepezil Hydrochloride, Rivastigmine Tartrate.

- Oncology Agents: Epirubicin Hydrochloride, Doxorubicin Hydrochloride.

- Others: Vitamin D derivatives, various specialized pharmaceutical intermediates.

2. Contract Manufacturing Services (CDMO)

- Custom synthesis for small molecule APIs.

- Process development and scale-up from pilot to commercial production.

- Regulatory support for DMF filings and cGMP compliance.

- Fermentation and chemical synthesis integration services.

3. Biotechnology Products

- Fermentation-derived products and specialized biochemicals.

- High-potency active pharmaceutical ingredients (HPAPIs).

4. Fine Chemicals

- Specialized chemical intermediates tailored for global pharmaceutical and industrial applications.